Mesa Laboratories Inc (MLAB)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 18,116 12,270 8,702 2,458 -9,329 -5,860 -1,805 -5,539 4,191 -1,723 -1,517 6,004 9,108 11,642 11,911 11,986 8,589 5,186 5,300 7,494
Revenue (ttm) US$ in thousands 237,747 228,380 223,712 216,187 212,874 213,688 219,272 219,080 222,368 222,777 199,868 184,335 163,420 142,896 138,916 133,937 130,181 127,664 121,340 117,687
Operating profit margin 7.62% 5.37% 3.89% 1.14% -4.38% -2.74% -0.82% -2.53% 1.88% -0.77% -0.76% 3.26% 5.57% 8.15% 8.57% 8.95% 6.60% 4.06% 4.37% 6.37%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $18,116K ÷ $237,747K
= 7.62%

Mesa Laboratories Inc's operating profit margin has exhibited fluctuating trends over the past several quarters. The margin started at a relatively healthy level of 6.37% in March 2020 but experienced a decline in subsequent quarters, reaching as low as -2.74% in September 2023. This period was characterized by negative operating profit margins, indicating the company's operational inefficiencies or decreasing profitability.

However, Mesa Laboratories Inc managed to improve its operating profit margin beginning in December 2023, with a positive trend observed in the subsequent quarters. The margin gradually recovered to 7.62% by December 2024, demonstrating the company's efforts to enhance operational efficiency and profitability.

It is essential for Mesa Laboratories Inc to sustain this positive momentum in its operating profit margin to ensure long-term financial health and stability. Continued focus on cost management, revenue growth strategies, and operational optimization will be crucial for maintaining and potentially further improving the operating profit margin in the future.